Asia Pacific cassava starch market was valued at US$ 1,965.2 million in 2023 and is projected to hit the market valuation of US$ 3,357.0 million by 2032 at a CAGR of 6.35% during the forecast period ...
Chido Nwangwu in this piece writes about a US-based Nigerian, Dr Patrick Okoye, who gets recognised recently as having the first United States Patent on Cassava Starch in medicines.
is taking bold steps to add value to its vast cassava output by producing pharmaceutical-grade starch, it emerged on Wednesday. The Director General/Chief Executive Officer (DG/CEO) of the Nigeria ...
Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial, causing the stock to plummet ~90% and trade near book value. The company's decision to discontinue other simufilam trials ...